interest. Meta-analysis has proven to be a valuable tool Studies examining outcomes in patients with ESRD are derived in many areas of contention in clinical medicine. Its sucfrom a variety of sources (single center, regional registries, cess lies in its ability as an approach to harmonize apparnational registries, etc.) and provide discrepant results as to ently conflicting findings by application of data pooling the impact of modality selection on patient survival. In an attempt to understand and resolve these discrepancies, an exand systematized study weighting. The success of metahaustive literature search and meta-analysis were performed to analysis, however, is dependent on the inherent values of compare survival in hemodialysis (HD) and peritoneal dialysis published data, the potential comparability of available (PD) patients using published data from both registry studies studies, and the level of required detail in the existing and non-registry studies. Results of the meta-analysis, based on data from 82 literature non-registry studies, 55 literature literature. In a sense, meta-analysis can be viewed as a registry studies, and two registry reports, censored for modality critical analysis tool that not only enlightens by determinswitches, transplants and dropouts and unadjusted for case ing validity of concepts or views, but also by uncovering mix, were inconclusive because survival and mortality outcomes varied with the data sources and formats for outcomes the merits or demerits of existing literature. In an attempt analyzed. Although limited data suggested that differences in to resolve the discrepancies in patient outcomes reported case mix may contribute to differences in survival outcomes, in ESRD, a meta-analysis was performed to compare adjustments for case mix (predialysis comorbid conditions), survival in peritoneal dialysis (PD) and hemodialysis adequacy of dialysis, and other important patient level covariates were not possible because of the paucity of available data.
METHODS

Studies examining outcomes in patients with end-stage
This study employed techniques for meta-analysis that renal disease (ESRD) are derived from a variety of represent the latest in the evolving science of review sources (single center, regional registries, national regisresearch [12] [13] [14] . Briefly, a study protocol was designed tries, etc.) and provide discrepant results as to the impact prospectively to define the study objectives, eligibility of modality selection on patient survival. These reports criteria for inclusion of trials, key data elements to be vary in their patient numbers (single center vs. national extracted, and analytical methods to be employed. Data registries), patient group selection (point prevalent vs.
extraction forms were designed and tested prior to impleperiod prevalent vs. incident), methods of data acquisimentation. Published studies were selected and data extion (governmental agencies, chart reviews, voluntary tracted by two reviewers (one physician and one research reporting), statistical approaches (as-treated vs. intentanalyst) working independently; data extraction forms to-treat), and adjustment for relevant variables that are were checked against one another and differences were known or expected to affect survival (comorbidity, ade- resolved by referring to the original papers. Registry quacy, etc.) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Additionally, a historical prospective data were extracted by a single reviewer and checked approach has been used by the United States Renal Data back against the tables in the registries from which the System (USRDS). This approach simulates a prospective data were extracted. Data from the data extraction forms study as it selects a historical start date and then is were entered into Excel spreadsheets for subsequent blinded to subsequent events to evaluate outcomes of storage in a customized relational database. Prior to locking the data set for statistical analysis, 100% verification was performed. were performed using SAS software version 6.11.
S-30
Prospective observational 22% 5% Prospective interventional 6% 0 a Values are given as percent of all studies.
RESULTS
Study characteristics
A total of 4289 citations were retrieved from MED-LARS (3936), Current Contents (133) fered HD.
Survival outcomes
Crude death rates were calculated as total number of registry) and hypertension (no studies), patients older than 60 or 65 (one non-registry and one registry study), or various racial or gender groups (one or fewer studies).
Results of the meta-analysis using unadjusted data, tween the non-registry and registry studies (37% vs. 15% summarized in Table 4 and Table 5 , were inconclusive patients with hypertension in literature non-registry and because survival and mortality outcomes varied with the registry studies, respectively). Representation of the two data sources and outcomes analyzed. Odds ratios and modalities was different between the two types of rerisk differences for death computed for the various cateports. Literature registry studies reported on only a very gories of studies, using unadjusted data, showed a greater small percentage of patients receiving PD (21% vs. 5% likelihood of deaths in the HD group (OR Ͼ 1 and RD Ͼ of patients in non-registry and registry studies, respec-0) for the literature non-registry studies (N ϭ 10) and the tively).
CORR registry report but greater likelihood of deaths in In both the non-registry and registry studies (Table the PD group (OR Ͻ 1 and RD Ͻ 0) for the literature 3) reporting on patients receiving HD, the number of registry studies (N ϭ 4) and ANZDATA registry report. sessions per week per patient (2. 8 and 2.7, respectively) Results were statistically significant for both the literaand mean time on dialysis per week (11.3 and 11.3 hours, ture non-registry studies and CORR registry report using respectively) were comparable; registry reports did not the FEM model and for the literature non-registry studreport this level of detail. There was little different beies using the REM model. tween studies published before or after 1986. The dialysis Odds ratios and risk differences for one-year survival prescription and dose delivered were reported too infrecomputed for the literature non-registry (N ϭ 11) and quently and too inconsistently to be analyzable. literature registry studies (N ϭ 5), using unadjusted data, In the non-registry studies reporting on patients reshowed a survival benefit in the PD group (OR Ͻ 1 and ceiving PD (Table 3) , the majority of cases involved RD Ͻ 0) in both categories of studies. In contrast, odds chronic ambulatory peritoneal dialysis (CAPD). Interratios and risk differences for five-year survival, which mittent peritoneal dialysis (IPD) and chronic cyclic pericould be computed only for literature registry studies toneal dialysis (CCPD) were reported separately so in-(N ϭ 4), showed a significant survival benefit for HD frequently as to be negligible in the data set. The mean number of exchanges per day was 4.3 (reported in 32
(OR Ͼ 1, RD Ͼ 0). No useful data were obtained from When odds ratio (OR) for death is Ͼ1, odds of death in HD is higher than PD; when odds ratio (OR) for survival is Ͼ1, odds of survival in HD is higher than PD; when risk difference (RD) for death is Ͼ0, risk of death in HD is higher than PD; when risk difference (RD) for survival is Ͼ0, survival in HD is higher than PD.
Abbreviations are: FEM, fixed effects model, REM, random effects model. the USRDS registry report since survival outcomes by (Ϫ0.176, Ϫ0.064)]; unfortunately, data were not availtype of dialysis were not presented. able to compute adjusted results for literature registry Limited data suggested that differences in case mix studies. An analysis of the subgroup of dialysis patients may contribute in large part to the observed differences with diabetes, which was possible only with the literature in survival outcomes (Table 6 and Table 7 ). For example, registry data, showed that diabetics had reduced survival while literature non-registry studies using unadjusted compared with nondiabetics, regardless of the type of data showed a significant survival advantage for patients dialysis used. receiving PD [meta-analysis based on 3 studies gave OR (death) ϭ (0.98, 1.54) and meta-analysis based on 11 DISCUSSION studies gave RD (death) ϭ 0.036 (0.009, 0.062)], the This meta-analysis of 82 literature non-registry studies opposite result was obtained using data adjusted for (Appendix 1), 55 literature registry studies (Appendix case mix [meta-analysis based on 3 studies gave OR (death) ϭ 0.53 (0.40, 0.71) and RD (death) ϭ Ϫ0.119
2), and registry reports from the US (USRDS), Canada When odds ratio (OR) for death is Ͼ1, odds of death in HD is higher than PD; when odds ratio (OR) for survival is Ͼ1, odds of survival in HD is higher than PD; when risk difference (RD) for death is Ͼ0, risk of death in HD is higher than PD; when risk difference (RD) for survival is Ͼ0, survival in HD is higher than PD.
Abbreviations are: FEM, fixed effects model, REM, random effects model.
(CORR), and Australia/New Zealand (ANZDATA) differences for death computed using unadjusted data from the literature registry studies (N ϭ 4) and the was unable to resolve the question of whether PD and HD provide equivalent survival outcomes for ESRD pa-ANZDATA registry report and by odds ratios and risk differences for five-year survival which could be comtients because results varied with the data sources and outcomes analyzed. A survival benefit in the PD group puted only from unadjusted literature registry data (N ϭ 4). was indicated by odds ratios and risk differences for death computed using unadjusted data from the literaLimitations of data sets ture non-registry studies (N ϭ 10) and the CORR registry report and by odds ratios and risk differences for This meta-analysis suffered from several limitations in the data sets analyzed. one-year survival computed using unadjusted data from literature non-registry studies (N ϭ 11) and literature Limited reporting by type of dialysis. Most of the studies retrieved were not included in the meta-analysis beregistry studies (N ϭ 5). In contrast, a survival benefit for the HD group was indicated by odds ratios and risk cause they reported only one type of dialysis, not both, or did not specify the type of dialysis at all. Notably, the in Canada obtained similar results using both a Poisson model, which censored patients at the first switch and largest data set available, the USRDS, did not report survival outcomes by type of dialysis. Further, modality thereby assessed purely PD and purely HD, and a Cox model, which assessed mixtures of PD and HD patients, representation in the available studies was highly variable, reflecting different utilization patterns and practice suggesting that the bias reflected by technique failures can be accounted for by proper analytic approaches. biases which may confound patient assignment and representation in different modalities. The differences were Potential for additional analyses markedly accentuated in several reports based on registries in which only a small percentage of patients were Given the limitations of the existing data sets in pubreported as receiving PD (21% vs. 5% of total patients lished reports, it is not clear whether additional analyses receiving PD in literature non-registry vs. registry studmight yield useful results. A meta-analysis of pooled ies, respectively). treatment groups, which would include all HD and PD Limited reporting on case mix. So few studies reported studies, not just those studies with both HD and PD outcomes by important patient level covariates, such as groups, would benefit from the increased data available concomitant diabetes or hypertension, age, gender, and for each of the treatment groups and increased informarace, that it was not possible to adjust for differences in tion on case mix. Although this approach would preclude case mix or draw conclusions about outcomes in subwithin-study linkages that permit direct comparisons begroups of interest. Of interest, several studies have found tween treatment groups, since these were not randomhigher comorbidity prevalence in patients treated with ized, controlled studies, the loss of within-study linkages PD compared with HD [2, 4, 8, 11] . In the one data may not be important. Additionally, in a pooled treatset where case mix could be examined, literature nonment group analysis, stratifying the data by year of publiregistry studies using unadjusted data showed a signification and by geographic location may allow an indirect cant survival advantage for ESRD patients receiving PD estimate of the adequacy of dialysis, since methods and [meta-analysis based on 10 studies gave OR (death) ϭ techniques have changed at different times in different 1.23 (0.98, 1.54) and meta-analysis based on 11 studies regions. Logistic regressions of the stratified data and a gave RD (death) ϭ 0.036 (0.009, 0.062)], but the opposite Bayesian inference of the year-stratified data also could result was obtained using data adjusted for case mix be explored for further information. [meta-analysis based on three studies gave OR (death) ϭ Although limited data suggested that differences in 0.53 (0.40, 0.71) and RD (death) ϭ Ϫ0.119 (Ϫ0.176, case mix may contribute to differences in survival out-Ϫ0.064)]. Results of the meta-analysis using adjusted comes, adjustments for case mix (predialysis comorbid data were not consistent with findings from five pubconditions), adequacy of dialysis, and other important lished studies that found equivalent survival for ESRD patient-level covariates were not possible because of the patients receiving PD and HD, analyzed using adjusted paucity of available data. These findings highlight the data in the Cox proportional hazards model [2, 3, 5, 7, 11] . limitations inherent in current literature reports and unLimited reporting on adequacy of dialysis. The paucity derscore the need for more uniform, standardized, and of data about the important features of dialysis predetailed approaches than has hitherto been the case in scribed and delivered precluded an analysis of the impact reporting outcome findings in ESRD. of the adequacy of dialysis on survival outcomes. A re- Adequacy Study [19, [abstract; Nephrol 6:606, 1995] and a large retrospective study of over 13,000 ESRD patients [20] showed that the relative REFERENCES risk of mortality increases sharply as the eKt/V decreases by which deaths were assigned to a treatment modality.
haemodialysis and renal transplantation. Lancet i: [1115] [1116] [1117] [1118] [1119] 1987 For example, deaths could be attributed inappropriately 
